XML 28 R11.htm IDEA: XBRL DOCUMENT
v3.26.1

Balance Sheet Components | 3 Months Ended
--- | ---
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Balance Sheet Components | Balance Sheet Components Prepaid and Other Current Assets Prepaid and other current assets consisted of the following (in thousands):
| March 31, 2026 |  | December 31, 2025
Prepaid research and development contract services | $ | 563 |  |  | $ | 115 |
Advanced professional fees | 319 |  |  | 193 |
Prepaid insurance | 208 |  |  | 367 |
Other prepaid expenses and other current assets | 162 |  |  | 73 |
Total prepaid and other current assets | $ | 1,252 |  |  | $ | 748 |
Property and Equipment, Net Property and equipment, net was comprised of the following (in thousands):
| March 31, 2026 |  | December 31, 2025
Equipment | $ | 1,661 |  |  | $ | 1,661 |
Furniture and fixtures | 258 |  |  | 258 |
Leasehold improvements | 132 |  |  | 132 |
Total property and equipment | 2,051 |  |  | 2,051 |
Less: accumulated depreciation | (1,802) |  |  | (1,756) |
Property and equipment, net | $ | 249 |  |  | $ | 295 |
Depreciation expense for the three months ended March 31, 2026 was an immaterial amount. For the three months ended March 31, 2025, depreciation expense was $0.1 million. Other long-term prepaid assets Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $1.0 million and $0.8 million for March 31, 2026 and December 31, 2025, respectively. Accrued Expenses Accrued expenses consisted of the following (in thousands):
| March 31, 2026 |  | December 31, 2025
Accrued professional fees | $ | 623 |  |  | $ | 818 |
Accrued compensation and benefits | 833 |  |  | 2,528 |
Accrued clinical trial and research and development costs | 3,345 |  |  | 2,298 |
Accrued interest | 1,080 |  |  | 741 |
Other accrued expenses | 34 |  |  | 42 |
Total accrued expenses | $ | 5,915 |  |  | $ | 6,427 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration